{
    "title": "105_hr1398",
    "content": "The \"Parkinson's Research Act of 1997\" aims to expand federal investment in Parkinson's disease research and improve coordination among National Institutes of Health research institutes. It also seeks to enhance care and assistance for individuals with Parkinson's and their family caregivers. The Director of NIH will establish a program for Parkinson's disease research and training, coordinating with national research institutes and holding research planning conferences every 2 years. The Director of NIH will establish a program for Parkinson's disease research and training, including the convening of research planning conferences every 2 years. Core Center Grants will be awarded to develop innovative research and training for Parkinson's, with up to 10 designated as Morris K. Udall Centers for Research on Parkinson's Disease. Center Grants will be awarded to develop innovative multidisciplinary research and training for Parkinson's disease. Each center funded will be designated as a Morris K. Udall Center for Research on Parkinson's Disease, conducting basic and clinical research. The Morris K. Udall Centers for Research on Parkinson's Disease conduct basic and clinical research, as well as training programs for scientists and health professionals, information dissemination to the public, and continuing education for health professionals. The Morris K. Udall Centers for Research on Parkinson's Disease conduct programs for information dissemination to health professionals and the public, establish a nationwide data system for Parkinson's patients, and create a Parkinson's Disease Information Clearinghouse. The Morris K. Udall Centers for Research on Parkinson's Disease aim to disseminate information to health professionals and the public, establish a national data system for Parkinson's patients, and create a Parkinson's Disease Information Clearinghouse. Additionally, they provide stipends for scientists and health professionals enrolled in training programs. The Morris K. Udall Centers for Research on Parkinson's Disease provide stipends for scientists and health professionals enrolled in training programs for a duration of up to five years, extendable upon review by a scientific peer group. The Director of NIH will establish a grant program for Parkinson's disease research excellence, providing grants for up to 5 years. $100,000,000 is authorized for this purpose. The grant program for Parkinson's disease research excellence will receive $100,000,000 for fiscal year 1998, with additional funding for 1999 and 2000. Funds cannot be used for research involving human fetal tissue from induced abortions for Parkinson's therapeutic applications. The grant program for Parkinson's disease research excellence will receive $100,000,000 for fiscal year 1998, with additional funding for 1999 and 2000. Restrictions apply to the use of human fetal tissue from induced abortions for Parkinson's therapeutic applications."
}